Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Harvey Garrett

Thoracic Surgery (Cardiothoracic Vascular Surgery) Memphis, TN Medical Doctor

NPI 1508800905 CMS profile 159307

6025 Walnut Grove Rd Ste 301, Memphis, TN 38120

Open in the dashboard

General payments

$711,548

503 records reported · program years 2019–2025

Research payments

$238,115

Paid to them · 61 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$836,449 paid to institutions, not to them · program years 2019–2024

Through program year 2025, Harvey Garrett of Memphis, TN is reported in the CMS Open Payments database as having received $711,548 across 503 general payments and $238,115 in research payments paid to them. Separately, studies naming them as principal investigator received $836,449 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $68,782 80
2024 General $140,613 105
2023 General $121,937 68
2023 Research $44,770 12
2022 General $164,953 94
2022 Research $10,475 12
2021 General $37,039 64
2021 Research $57,143 10
2020 General $79,410 41
2020 Research $60,475 11
2019 General $98,815 51
2019 Research $65,252 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Harvey Garrett
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Harvey Garrett were reported at $68,782. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Harvey Garrett Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $98,815 $886 $178–$3,167 $163
2020 $79,410 $341 $108–$1,605 $114
2021 $37,039 $453 $125–$1,886 $132
2022 $164,953 $695 $180–$2,566 $149
2023 $121,937 $745 $205–$2,662 $160
2024 $140,613 $799 $214–$2,967 $164
2025 $68,782 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Zimmer Biomet Holdings, Inc. $568,469 24 payments
  2. Abbott Laboratories $75,124 55 payments
  3. Endologix, Inc. $43,542 79 payments
  4. Silk Road Medical, Inc. $9,082 50 payments
  5. Medtronic, Inc. $5,339 24 payments
  6. W. L. Gore & Associates, Inc. $3,204 31 payments
  7. Penumbra, Inc. $1,040 12 payments
  8. Edwards Lifesciences Corporation $819 22 payments
  9. CryoLife, Inc. $665 35 payments
  10. LeMaitre Vascular, Inc. $461 17 payments
  11. Other $3,803 154 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $568,198 22 payments
  2. Consulting Fee $84,050 38 payments
  3. Food and Beverage $29,991 398 payments
  4. Travel and Lodging $25,895 41 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,800 1 payment
  6. Education $332 2 payments
  7. Long term medical supply or device loan $282 1 payment
Products named General payments · program years 2019–2025
  1. STERNALOCK 360 SYSTEM $401,212 15 payments
  2. SternaLock Blu $167,008 8 payments
  3. ENDOCROSS Device $16,979 24 payments
  4. Torus Stent Graft System $16,979 24 payments
  5. AFX2 Bifurcated Endograft System $12,123 18 payments
  6. ENROUTE Transcarotid Stent $9,059 49 payments
  7. ENROUTE Transcarotid Neuroprotection System $9,059 49 payments
  8. AFX $6,946 12 payments
  9. Alto Abdominal Stent Graft System $4,573 12 payments
  10. Endurant $2,985 4 payments
  11. Other $20,227 428 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $238,115 61 payments

Prescribing to Medicare patients

Part D · data year 2024 · 14 drugs

Part D claims

712

Median for Cardiac Surgery: 68

Drug cost

$94,758

Median for Cardiac Surgery: $445

Branded share of claims

68.5%

Median for Cardiac Surgery: 15.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Xarelto Rivaroxaban Brand 38 $36,892
Eliquis Apixaban Brand 32 $34,225
Brilinta Ticagrelor Brand 27 $14,990
Clopidogrel Clopidogrel Bisulfate Brand 343 $3,938
Prasugrel Hcl Generic 67 $3,010
Cilostazol Generic 44 $1,111
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 34 $143
Cephalexin Generic 27 $117
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 14 $86
Atorvastatin Calcium Generic 12 $84

The 10 drugs with the highest cost, of 14 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 411 Part D prescribers listed as Cardiac Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 207 billing codes

Paid by Medicare

$469,124

Medicare's payments for the services billed

Medicare patients

869

Average age 76

Services billed

2,020

362 women, 507 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 70%
Arthritis 55%
Diabetes 41%
Heart failure 39%
Chronic kidney disease 39%
Atrial fibrillation 37%
COPD 29%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

5 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
$62 32 —
XARELTO
$40 38 —
Exparel
$22 — —
Kcentra
$20 — —
KEYTRUDA
$19 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

564 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Tennessee

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record